Sample size calculation for meta-epidemiological studies

Statistics in Medicine

Volumn 35, Issue 2, 2016, Pages 239-250

  Giraudeau, Bruno ^a   Higgins, Julian P T ^b   Tavernier, Elsa ^c,d,e   Trinquart, Ludovic ^a,f,g,h  

^a Centre Cochrane Français   (France)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c PARIS DESCARTES UNIVERSITY   (France)

^d INSERM   (France)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g HÔTEL DIEU   (France)

^h Columbia University ^*  (United States)

Author keywords

Meta epidemiological study; Multilevel model; Sample size

Indexed keywords

ARTICLE; EPIDEMIOLOGY; META EPIDEMIOLOGICAL STUDY; POWER FUNCTION; SAMPLE SIZE; SIMULATION; STATISTICAL MODEL; STATISTICAL PARAMETERS; BIOSTATISTICS; COMPUTER SIMULATION; HUMAN; META ANALYSIS (TOPIC); PROCEDURES;

BIOSTATISTICS; COMPUTER SIMULATION; EPIDEMIOLOGIC STUDIES; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 84954386929     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6627     Document Type: Article

References (12)

1. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012; 157:429-438.
2. Trinquart L, Dechartres A, Ravaud P. Commentary: meta-epidemiology, meta-meta-epidemiology or network meta-epidemiology? International Journal of Epidemiology 2013; 42:1131-1133.
3. Welton NJ, Ades AE, Carlin JB, Altman DG, Sterne JC. Models for potentially biased evidence in meta-analysis using empirically based priors. Journal of the Royal Statistical Society: Series A (Statistics in Society) 2009; 172:119-136.
4. Siersma V, Als-Nielsen B, Chen W, Hilden J, Gluud LL, Gluud C. Multivariable modelling for meta-epidemiological assessment of the association between trial quality and treatment effects estimated in randomized clinical trials. Statistics in Medicine 2007; 26:2745-2758.
5. Sterne JAC, Jüni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in « meta-epidemiological » research. Statistics in Medicine 2002; 21:1513-1524.
6. Snijders TAB. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling 2nd ed. Sage: Los Angeles, 2012.
7. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Medicine 2007; 4:e78.
8. Davey J, Turner RM, Clarke MJ, Higgins JPT. Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Medical Research Methodology 2011; 11:160.
9. Higgins JPT, Whitehead A. Sequential methods for random-effects meta-analysis. Statistics in Medicine 2011; 30:903-921.
10. Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. International Journal of Epidemiology 2012; 41:818-827.
11. Lunn D, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing 2000; 10:325-337.
12. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Statistics in Medicine 2003; 22:2693-2710.